JP2019504623A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019504623A5 JP2019504623A5 JP2018538841A JP2018538841A JP2019504623A5 JP 2019504623 A5 JP2019504623 A5 JP 2019504623A5 JP 2018538841 A JP2018538841 A JP 2018538841A JP 2018538841 A JP2018538841 A JP 2018538841A JP 2019504623 A5 JP2019504623 A5 JP 2019504623A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine
- mastitis
- prevention
- treatment
- infection caused
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229960005486 vaccine Drugs 0.000 claims 13
- 208000015181 infectious disease Diseases 0.000 claims 8
- 208000004396 mastitis Diseases 0.000 claims 8
- 230000002265 prevention Effects 0.000 claims 8
- 239000003795 chemical substances by application Substances 0.000 claims 6
- 230000002163 immunogen Effects 0.000 claims 6
- 241000194017 Streptococcus Species 0.000 claims 5
- 239000002253 acid Substances 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 241000894006 Bacteria Species 0.000 claims 3
- 238000010438 heat treatment Methods 0.000 claims 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims 2
- 229920002307 Dextran Polymers 0.000 claims 2
- 239000002671 adjuvant Substances 0.000 claims 2
- 229940035032 monophosphoryl lipid a Drugs 0.000 claims 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims 1
- 108010042708 Acetylmuramyl-Alanyl-Isoglutamine Proteins 0.000 claims 1
- 241000208340 Araliaceae Species 0.000 claims 1
- 229920001503 Glucan Polymers 0.000 claims 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims 1
- 235000003140 Panax quinquefolius Nutrition 0.000 claims 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims 1
- 229930003427 Vitamin E Natural products 0.000 claims 1
- 229920000392 Zymosan Polymers 0.000 claims 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 claims 1
- 229910002092 carbon dioxide Inorganic materials 0.000 claims 1
- 239000001569 carbon dioxide Substances 0.000 claims 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims 1
- 235000008434 ginseng Nutrition 0.000 claims 1
- 238000011534 incubation Methods 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 238000007912 intraperitoneal administration Methods 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- BSOQXXWZTUDTEL-ZUYCGGNHSA-N muramyl dipeptide Chemical compound OC(=O)CC[C@H](C(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]1NC(C)=O BSOQXXWZTUDTEL-ZUYCGGNHSA-N 0.000 claims 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims 1
- 229930182490 saponin Natural products 0.000 claims 1
- 150000007949 saponins Chemical class 0.000 claims 1
- 229940032094 squalane Drugs 0.000 claims 1
- 229940031439 squalene Drugs 0.000 claims 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- 238000002255 vaccination Methods 0.000 claims 1
- 229940046009 vitamin E Drugs 0.000 claims 1
- 235000019165 vitamin E Nutrition 0.000 claims 1
- 239000011709 vitamin E Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16382060.8 | 2016-02-15 | ||
| EP16382060 | 2016-02-15 | ||
| PCT/EP2017/053306 WO2017140683A2 (en) | 2016-02-15 | 2017-02-14 | Streptococcus uberis extract as an immunogenic agent |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019504623A JP2019504623A (ja) | 2019-02-21 |
| JP2019504623A5 true JP2019504623A5 (enExample) | 2020-03-26 |
| JP6839199B2 JP6839199B2 (ja) | 2021-03-03 |
Family
ID=55646514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018538841A Active JP6839199B2 (ja) | 2016-02-15 | 2017-02-14 | 免疫原性剤としてのストレプトコッカス・ウベリス抽出物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10946085B2 (enExample) |
| EP (1) | EP3417049B1 (enExample) |
| JP (1) | JP6839199B2 (enExample) |
| KR (1) | KR102824686B1 (enExample) |
| AU (1) | AU2017220528A1 (enExample) |
| CA (1) | CA3012419A1 (enExample) |
| ES (1) | ES2960326T3 (enExample) |
| MX (1) | MX387200B (enExample) |
| PL (1) | PL3417049T3 (enExample) |
| WO (1) | WO2017140683A2 (enExample) |
| ZA (1) | ZA201805039B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2022352157A1 (en) | 2021-09-21 | 2024-05-02 | National Agriculture And Food Research Organization | Vaccine including nonencapsulated strain as antigen |
| EP4570265A1 (en) | 2023-12-15 | 2025-06-18 | Zaklad Badawczo-Wdrozeniowy Osrodka Salmonella "Immunolab" Sp. z o.o. | Vaccine for use in preventing inflammatory conditions in cows |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60243024A (ja) * | 1983-12-29 | 1985-12-03 | Kitasato Inst:The | ストレプトコツカス・サンギス感染症予防用ワクチン，診断用抗原および抗体 |
| CA2059693C (en) * | 1991-01-28 | 2003-08-19 | Peter J. Kniskern | Polysaccharide antigens from streptococcus pneumoniae |
| CA2222701C (en) | 1995-06-08 | 2012-02-07 | University Of Saskatchewan | Camp factor of streptococcus uberis |
| DK1332155T3 (da) | 2000-06-12 | 2007-02-26 | Univ Saskatchewan | Vaccination af malkekvæg med GapC protein mod streptokokinfektion |
| US20070231335A1 (en) * | 2005-07-20 | 2007-10-04 | Bruce Beutler | Compositions and methods for treating Gram positive bacterial infection in a mammalian subject |
| US8273361B2 (en) | 2006-09-26 | 2012-09-25 | Infectious Disease Research Institute | Vaccine composition containing synthetic adjuvant |
| US20110028407A1 (en) * | 2007-02-09 | 2011-02-03 | Jutila Mark A | Enhancement of innate resistance to infection |
| GB0818231D0 (en) | 2008-10-06 | 2008-11-12 | Univ Nottingham | Composition |
| EP3461496B1 (en) * | 2009-06-22 | 2023-08-23 | Wyeth LLC | Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions |
| WO2012116447A1 (en) | 2011-03-03 | 2012-09-07 | The Governors Of The University Of Alberta | Use of bacterial endotoxins and lipoteichoic acids to improve postpartal health and productivity of dairy cows and their newborns |
| MX2013013182A (es) | 2011-05-12 | 2013-12-09 | Intervet Int Bv | Tratamiento de la mastitis. |
| BR112013032675A2 (pt) * | 2011-06-19 | 2017-08-08 | Vaxine Pty Ltd | composição adjuvante de vacina compreendendo partículas de inulina |
| WO2015042423A2 (en) | 2013-09-19 | 2015-03-26 | Zoetis Llc | Vaccine |
-
2017
- 2017-02-14 CA CA3012419A patent/CA3012419A1/en active Pending
- 2017-02-14 AU AU2017220528A patent/AU2017220528A1/en not_active Abandoned
- 2017-02-14 KR KR1020187021575A patent/KR102824686B1/ko active Active
- 2017-02-14 MX MX2018009048A patent/MX387200B/es unknown
- 2017-02-14 PL PL17704038.3T patent/PL3417049T3/pl unknown
- 2017-02-14 JP JP2018538841A patent/JP6839199B2/ja active Active
- 2017-02-14 WO PCT/EP2017/053306 patent/WO2017140683A2/en not_active Ceased
- 2017-02-14 ES ES17704038T patent/ES2960326T3/es active Active
- 2017-02-14 EP EP17704038.3A patent/EP3417049B1/en active Active
- 2017-02-14 US US16/075,092 patent/US10946085B2/en active Active
-
2018
- 2018-07-26 ZA ZA2018/05039A patent/ZA201805039B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2605834C2 (ru) | Поливалентная композиция, содержащая конъюгаты пневмококковый полисахарид-белок | |
| RU2606152C1 (ru) | Мультивалентная композиция на основе конъюгатов пневмококковый полисахарид-белок | |
| HRP20221438T1 (hr) | Postupak glikokonjugiranja | |
| MY182282A (en) | Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof | |
| WO2014009971A3 (en) | Non-alcoholic vaccine compositions free from animal- origin and process for preparation thereof | |
| JP2012006969A5 (enExample) | ||
| NZ760783A (en) | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | |
| PE20211888A1 (es) | Composiciones que comprenden conjugados de polisacarido de streptococcus pneumoniae con proteina y sus metodos de uso | |
| CN110520154B (zh) | 多价肺炎链球菌疫苗组合物 | |
| BR112018007812A2 (pt) | polissacarídeo capsular, processo para preparar um polissacarídeo capsular e para fabricar uma vacina, composição imunogênica, vacina, métodos para tratamento ou prevenção de uma infecção, para imunizar um hospedeiro humano e para induzir uma resposta imune, e, uso de uma composição imunogênica. | |
| RU2016127123A (ru) | Капсульные полисахариды Streptococcus pneumoniae и их конъюгаты | |
| RU2017145963A (ru) | Составы вакцин против неоплазии и способы их получения | |
| JP2022130637A5 (enExample) | ||
| CA2618306A1 (en) | Inactivating pathogens with hydrogen peroxide for vaccine production | |
| JP2011506334A5 (enExample) | ||
| JP2019504623A5 (enExample) | ||
| JP2016516721A5 (enExample) | ||
| BR112023021812A2 (pt) | Composição vacinal adjuvantada e métodos | |
| JP2019509300A5 (enExample) | ||
| WO2011112906A3 (en) | Novel immunogens and methods for discovery and screening thereof | |
| RU2480237C1 (ru) | Ассоциированная вакцина для профилактики сибирской язвы и некробактериоза животных | |
| JP2015091795A (ja) | 鼻粘膜ワクチン組成物 | |
| JP2017509713A5 (enExample) | ||
| WO2024261351A3 (en) | Immunologically active saponin fractions and adjuvant formulations | |
| RU2014147491A (ru) | Антигены и антигенные композиции |